Chicago-based Sibel Health, a medical technology company, has been picked by the capital region of Denmark for a long-term partnership in conjunction with Dräger, a medical safety technology company, to deploy advanced continuous monitoring in the hospital setting.
Sibel Health's FDA-cleared ANNE One platform contains advanced wearable sensors, AI-enabled data analytics and an integrated mobile...
Sibel Health, a spin-out of Northwestern University, announced the release of its physiological monitoring platform for clinical trial use dubbed Discovery alongside a partnership with AI-powered clinical trial solutions company Medidata.
The Illinois-based healthcare technology platform Discovery utilizes its FDA-cleared wearable sensors to monitor participants' digital endpoints and vital...
Sibel Health, spun out of Northwestern University, announced it received a new FDA 510(k) clearance for its ANNE One platform to include continuous neonate and vital sign monitoring of infants born at any gestational age up to 2 years old.
The ANNE One platform allows for this vital sign monitoring via a clinical-grade wearable in two parts: the Anne limb, which measures skin and body temperature...
AI-backed remote monitoring and digital therapeutics company Biofourmis added another $20 million to its Series D round, bringing its raise to $320 million.
The extension funding comes from Intel Capital, the strategic investment division of chipmaker Intel. The company first announced its Series D in April, which boosted Biofourmis to unicorn status with a valuation of $1.3 billion.
Biofourmis...
NHS PROVIDERS PUBLISHES GUIDE FOR DIGITAL TRANSFORMATION
Membership organisation for the NHS Hospitals, NHS Providers, has published a guide to NHS digital leadership to help trust leaders build on the momentum made during COVID-19 and to support NHS boards lead their organisations through the digital transformation.
Newly published material also includes, ‘why digital transformation matters’,...
